| [1] |
MU Xin, ZHAO Ying, ZHANG Lan, CUI Yimin, ZHANG Yongxiang, DU Guanhua.
Drug clinical trial of COVID-19 in China: A brief analysis
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2020, 25(8): 869-877.
|
| [2] |
WANG Xiaomin, YANG Guoping, WANG Bing, ZHONG Yuqiong, WU Ying, LIU Xing.
Ethical issues in the prevention and control of Coronavirus Disease 2019
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2020, 25(3): 329-333.
|
| [3] |
CUI Cheng, YAO Xueting, TU Siqi, XIE Jieen, LI Haiyan, LIU Dongyang.
Advances of the clinical pharmacology of hydroxychloroquine sulfate
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2020, 25(2): 221-226.
|
| [4] |
LUO Yi, JIANG Zhiwei.
Statistical consideration in the design of COVID-19 clinical trials in emergency
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2020, 25(2): 121-125.
|
| [5] |
HU Ke.
New coronavirus pneumonia: Question and confusion
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2020, 25(2): 141-143.
|
| [6] |
ZHANG Wenxi, LIU Donghong, ZHAO Bei, ZHAO Jiajia, CAI Qiao, GAO Wei, CAI Benben.
A randomized controlled clinical trial of azithromycin combined with methylprednisolone in treating pulmonary consolidation from mycoplasma pneumonia
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2018, 23(9): 1052-1055.
|
| [7] |
ZHANG Wenxi, GAO Wei, ZHAO Jiajia, CAI Qiao, ZHAO Bei, ZHENG Yan.
Curative effect of erythromycin in the treatment of ureaplasma mycoplasma pneumonia and its influence on cell subset and liver function
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2018, 23(2): 194-198.
|
| [8] |
ZHENG Yan-hua , CHEN Yu, GU Lei.
Clinical effect of meropenem and cefoperzone/sulbactan for acute leukemia with severe bacterial pneumonia
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2014, 19(3): 309-312.
|
| [9] |
WU Zhi-qiang.
A randomized study of sequential intravenous/oral moxifloxacin in comparison to sequential intravenous ceftriaxone/oral cefuroxime axetil in patients with hospital-acquired pneumonia
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2013, 18(4): 424-429.
|
| [10] |
YAN Han, LIU Shu-hua, DU Mi-wen, HUANG Hong-chun, ZHAO Zhi-ming, WANG Shun.
Analysis of risk factors and feature of pathogens and clinical treatment to the old pneumonia patients
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2009, 14(1): 94-97.
|
| [11] |
ZHAO Gang, HU Hui-Dong.
Clinical study of lovofloxacin combined with amikacin in the treatment of the patients with pneumonia
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2002, 7(1): 71-72.
|
